Table 1 Patients’ demographics of all included patients after curative intended pancreas surgery due to pancreatic ductal adenocarcinoma (n = 251)
Median (range) | |
Age (years) | 67 (30–88) |
BMI (kg/m2) | 24.6 (15–39) |
n (%) | |
Gender (female/male) | 131/120 (52%/48%) |
Smokers | 53 (21%) |
Alcohol abuse | 28 (11%) |
ASA Score [12] | |
I | 13 (5%) |
II | 152 (61%) |
III | 81 (33%) |
IV | 3 (1%) |
Common comorbidities | |
Hypertension | 133 (54%) |
Post pancreatitis | 125 (50%) |
Hepatic disease | 100 (40%) |
Coronary heart disease | 43 (17%) |
Pulmonary disease | 33 (13%) |
Renal insufficiency | 30 (12%) |
Diabetes | 28 (11%) |
Localization of tumor | |
Head | 209 (83%) |
Body | 16 (7%) |
Tail | 26 (10%) |
Type of surgery | |
Pancreatoduodenectomy | 190 (76%) |
Distal pancreatectomy | 29 (13%) |
Total pancreatectomy | 32 (11%) |
Complications | |
Intraoperative complication | 18 (7%) |
Postoperative complication | 143 (57%) |
Operative revision | 38 (15%) |
median (range) | |
Hospital stay (days) | |
Overall | 18 (7–63) |
Intensive care unit | 5 (1–32) |
Drain remove (days) | 7 (0–62) |